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Poly(L-lactic acid) (PLLA) and poly(ethylene oxide) (PEO) blends were prepared by mechani-
cal mixture and fusion of homopolymers. Samples were submitted to in vitro degradation tests
(immersion in a phosphate buffer solution with pH = 7.4 at 37 °C). Independently of the blend
composition, PEO was dissolved after 14 days of immersion. As expected, after immersion, scanning
electron microscopy showed that the blends were porous, contrary to the samples, which were not
immersed in the buffer solution. Phase separation was not evident. Using differential scanning
calorimetry, the melting points (Tm) of both PLLA and PEO crystalline fractions were observed and
remained practically constant, indicating no miscibility. Thermogravimetry showed that the tem-
perature where the main mass loss stage starts (Tonset), depended on the blend composition and
period of immersion in the buffer. The blends and the PLLA homopolymer were implanted in defects
produced in the tibias of rats. The blends were as biocompatible as the PLLA. 
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1. Introduction
Biodegradable polyesters based on poly(L-lactic acid),
PLLA, have been used as biomaterials for temporary thera-
peutic applications mainly in orthopedic devices, control-
led drug release and support for cell culture1-4. The main
advantage of PLLA is its degradation by simple hydrolysis
of the ester backbone in aqueous environments such as
body fluids. This makes it very convenient for devices with
a temporary function. The degradation products are finally
metabolized to carbon dioxide and water or excreted via
the kidneys, so is not necessary to remove the device from
the implantation site after tissue healing1,5. Pure PLLA
devices in general have a long degradation time6-9.
Mainil-Varlet and co-workers have been using poly(L-
lactic acid) and poly(DL-lactic acid) in implants in the tibia
of sheep and verified that the absorption of these materials
were not complete even after one year of implantation; the
molecular weight, however, decreased from 40000-50000
to 500-3000 g/mol8.
PLLA degradation and biocompatibility have been in-
vestigated in rats. The histological reaction in PLLA im-
plants is slow but, the decrease in the polymer molecular
weight is fast. The complete absorption of PLLA has not
been observed in rats and it has been estimated that this
phenomenon should occur after 3.5 years of implantation6.
Based on the positive results observed for animals,
PLLA has been used in the fixation of bone fractures in
humans. After 3.5 years of implantation, the slow polymer
degradation caused a swelling of the implanted region,
without however the necessity of extracting the implant10.
An alternative procedure to change degradation time, is
the blending of PLLA with other polymers, which can be
degradable or non-degradable polymers. In general, this
kind of blends exhibits advantageous physical and me-
chanical properties5,11. The degradation time of the device
can be varied from months to years, depending on its
amorphous/crystalline and hydrophilic/hydrophobic pro-
perties5,12.
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Most of the investigated systems represent mixtures of
two amorphous polymers, such as poly(phenylene ox-
ide)/polystyrene, or mixtures in which one of the compo-
nents is semi-crystalline, such as poly(vinyl
chloride)/caprolactone12. Semi-crystalline/semi-crystal-
line polymer blends, which have been reported in literature,
include poly(vinylidene fluoride)/(acrylates)13, poly(ethyl-
ene oxide)/poly(hidroxybutyrate)14, poly(vinylidene fluo-
ride)/poly(hidroxybutyrate)15,
poly(caprolactone)/poly(carbonate)16-18, poly(vinylidene
fluoride)/poly(1,4-butylene adipate)19,20. In these systems,
the phase behavior and morphological properties have been
investigated.
Meikle and co-workers implanted poly(DL-lactic
acid)/poly(glycolic acid) blends into the head of rabbits,
using as a control spontaneous bone regeneration. By his-
tomorphometry analysis they verified that the differences
in bone regeneration were not statistically significant, after
1, 2 or 3 months of implantation21, when compared to the
control.
Poly(ethylene oxide), PEO, is a hydrophilic non-de-
gradable polymer, while PLLA is hydrolytically degrad-
able and hydrophobic. Both of these polymers are
semi-crystalline. PEO is also of particular interest in
biomedical applications mainly due to its good biocompati-
bility and low toxicity. The glass transition temperatures of
PEO and PLLA are -54 °C and 57 °C, and the melting
temperatures are 74 °C and 180 °C, respectively11. Blends
of PLLA and poly(ethylene oxide)11,22-24 or poly(ethylene
glycol)25-27 have been described in literature, where their
miscibility, compatibility and mechanical properties are
focused on. In these cases, the blend preparation was car-
ried out from the mixture of the homopolymers which were
dissolved in a common solvent.
It has been verified that PLLA/PEO blends, which were
submitted to the degradation process by immersion into a
buffer solution, became porous due to the PEO fraction
dissolution, while pure PLLA films remained dense. This
porous morphology depended on the method employed for
the blend preparation. In a previous research, blends were
prepared from the casting of a solution containing both
PLLA and PEO dissolved homopolymers. In these cases,
the pores had a circular shape and their dimension de-
pended on the composition of the blend28.
A porous morphology can promote film hydration,
which plays an important role in the PLLA degradation rate
via hydrolysis of the ester backbone. The PEO fraction
dissolution could also be interesting in cases where soluble
drugs in the PEO fraction could be controlled delivered. A
porous morphology can also be very desirable in most of
biomedical applications. In some cases, the polymeric ma-
trix must present a uniform and interconnected porous
structure to allow cell growth to be easily distributed
throughout the device. This way, an organized network of
the tissue constituents can be formed.
Here, the poly(L-lactic acid)/poly(ethylene oxide)
blends, which were prepared by mechanical mixture and
fusion of the homopolymers, were investigated. PLLA
homopolymer and PLLA/PEO blends were implanted into
defects produced in the tibia of rats, in order to investigate
blend biocompatibility and its potential application in the
manufacturing of devices used for bone repair. The first in
vivo results obtained for 50/50 (w/w) PLLA/PEO blends
after 2 and 4 weeks of implantation, are presented here. The
results for longer periods of implantation and for 80/20 and
20/80 PLLA/PEO blends are in progress.
2. Experimental
Blends were prepared by mixing PLLA (Medisorb;
MW = 300000 g/mol) and PEO (Aldrich; MW = 200000
g/mol) in a mini injector LMM-2017 Mini Max Molder.
Sticks of PLLA and PLLA/PEO of different compositions
(80/20, 50/50 and 20/80 w/w) were prepared by the melting
of homopolymers at 190 °C, using a 2.0 mm diameter and
9.3 cm high (internal dimensions) mold, which remained
at 120 °C during the processing. The heating of the ho-
mopolymer mixture was carried out for 1 min followed by
2 min of shearing and mold injection. The mold was cooled
at room temperature for 20 min.
In vitro degradation tests were carried out using 80/20,
50/50 and 20/80 PLLA/PEO blends. Samples were im-
mersed in a buffer solution (KH2PO4 – NaOH; pH = 7.4)
at 37 °C, which was changed all week. Tests were per-
formed during a 2-week period. These conditions have
often been referred to in literature as degradation tests27, 29.
Blends were immersed for different periods (7 or 14
days). After each period, samples were dried at 50 °C until
they reached a constant mass, and characterized as de-
scribed below. The mass loss percentage was calculated
comparing the mass values of the samples before and after
submitting them to degradation tests. Samples are denoted
here as a function of the degradation time. PLLA/PEO t = 0
was used for blends that were not immersed in the buffer
solution, and PLLA/PEO t = 7 or t = 14 days was used for
blends after the degradation process.
Samples were fractured by immersion into liquid nitro-
gen. Surface fracture was covered with gold by sputtering
and observed in a JEOL JXA 840 scanning electron micro-
scope.
Thermogravimetric analysis was carried out in a TG209
Netzsch thermal analyzer from 25 to 800 °C at 10 °C.min-1
under nitrogen.
Differential scanning calorimetry was performed in a
DSC200 Netzsch thermal analyzer using the following
temperature program: rapid cooling from 25 to -100 °C;
heating from -100 to 200 °C at 10 °C.min-1; isotherm at
200 °C for 5 min; cooling from 200 to -100 °C  at
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10 °C.min-1; isotherm at -100 °C for 5 min; heating from
-100 to 200 °C at 10 °C.min-1. Samples were analyzed
under nitrogen.
Dynamic-mechanical analysis was performed in a
409 DMA Netzsch thermomechanical analyzer from -100
to 230 °C, under air, using the following conditions: duo
cantilever mode, force = 1N, amplitude = 15 µm and
frequency = 1 Hz.
In vivo tests were carried out following a standard
method described in reference 30. Fifty-two male Wistar
rats (200 - 250 g) were used in the study. Prior to surgery,
the animals were anaesthetized with a solution of Ketamine
plus Xylazine administered by an intramuscular injection
using a dose of 1.5 mL per kg of body weight. After the
asepsis of the site, a longitudinal incision in the skin,
approximately 1 cm long, parallel to the tibia, was carried
out. The muscular tissue was parted and moved away until
the periosteum appeared. With a low rotation mini motor
and a 3.0 mm diameter drill, sockets were produced in the
tibia in order to allow the introduction of the test bodies in
the shape of a 2 mm diameter and 2 mm long toggle. This
procedure was carried out in the legs of all animals, which
were divided into the following groups: the PLLA/PVC
group: 20 animals received PLLA in the tibia of their left
leg, and poly(vinyl chloride) PVC in the tibia of their right
leg as a control. The BLEND/PVC group: 20 animals
received the 50/50 PLLA/PEO blend in the tibia of their
left leg and poly(vinyl chloride) PVC in the tibia of their
right leg as a control. The CONTROL group: 12 animals
were submitted to surgery for the insertion of a socket in
the tibia of the left leg, in which test bodies were not
implanted.
Immediately after the insertion of the sockets and/or
rank of the test bodies, the muscular tissue was sutured.
During all this process, the area was continuously irri-
gated with a physiological solution, so the heating of the
tissue did not occur. After the skin suture, the surface was
washed with an anti-septic solution. During the post-surgi-
cal periods the animals received doses of an analgesic
diluted in water in a dose 2.5 mL/L, supplied for 2 days
after the surgery. The animals remained lodged in river
steamers in groups of 3 animals for each streamer, with
burst light and ventilation, with solid ration and water
supply without restriction. 
After 2, 4, 8 and 16 post-surgical weeks, the animals
were killed by an intraabdominal injection with an over-
dose of 10% Chloral Hydrate solution, after which speci-
mens of the tissue were removed. Immediately, the bone
specimens were fixed in a 10% formal solution at room
temperature, for 48 h. Decalcified sections were made and
stained with hematoxylin and eosin (HE) for histological
observations under a light microscope.
Test bodies of PVC (Aldrich) were prepared from the
casting of a 5wt% polymer/THF solution. Thick films
(2 mm of thickness) were cut in a 2 mm diameter disk
shape.
3. Results and Discussion
Table 1 shows the mass loss percentage for PLLA/PEO
blends occurred during the period of 14 days of in vitro
degradation. The highest mass loss percentage occurred
during the first week of the in vitro degradation. This
process is related to the water diffusion in the blend fol-
lowed by the dissolution of the PEO fraction. Since the
PLLA fraction presents a low degradation rate, mass loss
practically did not change during the period from 7 to 14
days of degradation.
Figure 1 shows the surface fracture of PLLA/PEO
blends of different compositions observed by scanning
electron microscopy as a function of the degradation time.
For samples which were not immersed into the buffer
solution (t = 0), the occurrence of phase separation was not
clear. Contrary to 80/20 PLLA/PEO which presented a
dense morphology, pores with a circular shape and differ-
ent dimensions (near 1 to 10 µm), could be observed for
blends containing higher PEO contents. 
After a period in a buffer, all the channels could be
observed. The morphology of the blends (t = 7days) was
similar to that shown for blends (t = 14 days). For 80/20
PLLA/PEO blends channels with holes in them are distrib-
uted in a dense structure, while for 20/80 PLLA/PEO
blends, the channels are distributed into a more porous
structure. For 50/50 PLLA/PEO blends, an intermediate
situation was verified, where the dense structure became
cracked and surrounded by channels with holes in them.
Figure 2a shows the thermal analysis measurements for
pure PLLA, pure PEO and PLLA/PEO blends (t = 0). For
blends two main thermal degradation processes were ob-
served. The first one was due to the PLLA, and the second
one to the PEO thermal degradation processes, respec-
tively. After the immersion in the buffer, one main mass
loss stage was observed for 80/20 and 50/50 PLLA/PEO
blends, Fig. 2b. Considering that the PEO fraction is ex-
tracted during the in vitro degradation tests, this mass loss
stage was due to the thermal degradation process of the
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Table 1. Mass loss percentage obtained from the in vitro degradation tests
for PLLA/PEO blends of different compositions as a function of the period
of immersion in the buffer.
PLLA/PEO
Mass loss percentage (%)
t = 7 days t = 14 days
80/20 18.7 19.9
50/50 47.0 46.0
20/80 71.0 80.2
PLLA fraction. For 20/80 PLLA/PEO blends (t = 7 or t =14
days) a second mass loss stage near 400 °C was also
observed. Although the in vitro degradation tests and dif-
ferential scanning calorimetry had indicated that PEO is
absent after 14 days of immersion in a buffer, this second
mass loss process could be assigned to one PEO fraction,
which had not yet dissolved. 
Table 2 shows Tonsed values as a function of the blend
composition and the immersion time. Tonset represents the
temperature where the main thermal degradation stage
starts. For blends, Tonset, after the immersion in the buffer,
was lower than that observed for blends t = 0, except for
the 80/20 PLLA/PEO composition, indicating that the in-
corporation of PEO in the PLLA and its posterior extrac-
tion, may favor the thermal degradation of PLLA. In all
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Figure 1. Scanning electron microscopy of (a) 80/20, (b) 50/50 and (c) 20/80 PLLA/PEO blends t = 0 (left hand side) and t = 14 days (right hand side).
cases, the residue percentage at 800 °C  was  lower  than
5%.
For differential scanning calorimetry, the results ob-
tained from the second heating, have been shown. Figure 3
shows the curves for PLLA/PEO blends t = 0 and t = 7. For
pure PLLA a transition near 50 °C was observed, which
was assigned to the glass transition temperature, Tg, and the
polymer melting which occurred at 174 °C. For pure PEO
an endothermic peak at 67 °C was observed and assigned
to the polymer melting. The PEO glass transition, which
occurred near -55 °C, could not be visualized. 
For PLLA/PEO blends, PEO glass transition was also
not evident, probably due to the high crystallinity of the
sample. Due to the overlapping of the melting endothermic
of PEO and the glass transition of PLLA, Tg of PLLA was
not determined. So, the Tg method to evaluate miscibility
could not be applied to the PLLA/PEO blends. In these
cases, the melting temperature (Tm) depression method can
be used.
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Figure 2.  (a) Thermogravimetric curves of (-..-..-) pure PLLA, (-.-.-) pure
PEO, (–) 80/20, (- - -) 50/50 and (. . . .) 20/80 PLLA/PEO blends (t = 0).
(b) Thermogravimetric curves of (–) 80/20, (- - -) 50/50 and (. . . .) 20/80
PLLA/PEO blends (t = 14 days).
Table 2. Tonset values for PLLA/PEO blends of different compositions as a function of the period of immersion in the buffer. In parenthesis, the mass
loss percentage associated to the process, is given.
PLLA/PEO
Tonset (°C) t = 0 Tonset (°C) t = 7 days Tonset (°C) t = 14 days
1st Stage 2nd Stage 1st Stage 2nd Stage 1st Stage 2nd Stage
100/0 306 ---- ---- ---- ---- ----
80/20 302 (85) 400 314 ---- 294 ----
50/50 318 (60) 400 286 ---- 278 ----
20/80 275 (25) 371 274 388 (10) 274 400 (12)
0/100 257 ---- ---- ---- ---- ----
Figure 3.  (a) Differential scanning calorimetry curves of (–) 80/20,
(- - -) 50/50 and (. . . .) 20/80 PLLA/PEO blends (t = 0). Second heating.
(b) Differential scanning calorimetry curves of (–) 80/20, (- - -) 50/50 and
(. . . .) 20/80 PLLA/PEO blends (t = 7 days). Second heating.
A composition-dependent melting endotherm usually
indicates a miscible blend, whereas a fully phase separated
immiscible system will display a constant Tm. Under com-
plete immiscibility conditions, each of the crystallizable
components of the mixture will exhibit the Tm of the
corresponding pure homopolymer.
Table 3 shows the values of Tm for run 1 (Tm1) and run
2 (Tm2) of pure PLLA, pure PEO and for the binary mixture
with different weight fractions. The melting temperature of
PLLA is almost constant for both run 1 and run 2, inde-
pendently of the blend composition, suggesting that there
were no interactions between PLLA and PEO molecules in
the mixture as grown from fusion and melt-crystallized
samples. For PEO, both Tm1 and Tm2 decreased slightly
with the increasing PLLA in the mixture, but this change
may be due to the morphological effects. PEO seems to be
more sensitive to the presence of PLLA chains, while a
much smaller influence is exerted by PEO on the crystalline
phase of PLLA. This behavior can be related to the different
degrees of crystallinity of both polymers, with PEO being
more crystalline. Therefore, relatively small PLLA con-
tents will interfere with the PEO crystalline array, causing
shifting of the melting temperature. For PLLA, consider-
able amounts of PEO can blend with the amorphous phase
of PLLA, without significantly affecting the crystalline
domains.
Table 4 shows the variation of the fusion enthalpy (∆Hf)
of PLLA and PEO, which was correlated with the blend
composition, for run 1 and run 2. Independent of the blend
composition, ∆Hf values of PEO for run 2 decreased com-
pared with run 1. Crystallization of PLLA is complete
before crystallization of PEO commenced, showing that the
two polymers crystallize in different and well-separated
temperature regime. The crystallization of PEO seems to
be severely hampered by PLLA, which may be explained
by the fact that the PLLA component has already com-
pletely solidified at the temperatures where PEO crystal-
lizes, thus restricting free crystal growth for this polymer.
For PLLA/PEO blends, which were immersed in a
buffer, independent of the immersion time or the blend
composition, only one endothermic process could be ob-
served. Table 5 shows Tm and ∆Hf values for samples which
were immersed in the buffer solution. Comparing with
non-immersed samples, Tm values for blends t = 7 or t =14
days were slightly lower than t = 0. In relation to ∆Hf, the
values were lower after immersion in a buffer, except for
the 80/20 PLLA/PEO blends, where ∆Hf  actually increased
slightly. It is interesting to note that the variation of ∆Hf
was more drastic for the 20/80 PLLA/PEO blends. In this
case, immersed samples seemed to be much more amor-
phous than non-immersed ones. ∆Hf is directly related to
the degree of crystallinity. During the immersion of a
semi-crystalline polymer in a buffer, if degradation occurs,
it is expected that the amorphous fraction degrades before
the crystalline one does. So, one would also expect that the
crystallinity of the remaining porous matrix, to increase
with degradation time, since the amorphous phase was
being removed. After this process, the degradation of the
crystalline fraction started and consequently a decrease in
the degree of crystallinity was expected. The results shown
in Table 5 can indicate that, depending on the blend com-
position, it would be possible to control the degradation rate
of the material. Using higher contents of PEO the material
seems to be more susceptible to the degradation process.
Figure 4 shows the dynamic-mechanical curves ob-
tained for the homopolymers and PLLA/PEO blends t = 0.
For pure PEO one can observe two transitions, which
occurred near -10 °C and the other near 100 °C. For pure
PLLA two main transitions were observed near 100 °C and
200 °C. In both PEO and PLLA homopolymers, the first
Table 3. Melting temperatures Tm1 and Tm2 for run 1 and run 2 of pure
PLLA, pure PEO and PLLA in the mixture with PEO. These values
correspond to t = 0.
PLLA/PEO Tm1 (°C) Tm2 (°C) Tm1 (°C)* Tm2 (°C)*
100/0 173 163 ---- ----
80/20 179 175 65 59
50/50 179 173 68 61
20/80 178 175 73 64
0/100 ---- ---- 69 66
* Melting temperatures of PEO in the mixture with PLLA.
Table 4. Fusion enthalpy variation values of PLLA and PEO corrected
as a function of the blend composition, for run 1 and run 2. These values
correspond to t = 0.
PLLA/PEO ∆Hf of
PLLA (J/g)
∆Hf of
PLLA (J/g)*
∆Hf of
PEO (J/g)
∆Hf of
PEO (J/g)*
100/0 65 66 ---- ----
80/20 54 47 130 103
50/50 71 66 152 125
20/80 76 80 168 142
0/100 ---- ---- 166 160
* ∆Hf values for run 2.
Table 5. Melting temperature and fusion enthalpy variation values (for
run 2) for PLLA/PEO blends which were immersed in the buffer for 7 or
14 days.
t = 7 t = 14
PLLA/PEO Tm (°C) ∆Hf (J/g) Tm (°C) ∆Hf (J/g) 
80/20 172 50 171 51
50/50 170 52 147 46
20/80 167 39 166 29
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transition could be due to the glass transition and the second
one to the melting of the polymer. For blends, the mechani-
cal properties are determined primarily by the mutual solu-
bility of the two homopolymers. If two polymers are
completely soluble in one another the properties of the
mixture are nearly the same as those of a random copolymer
of the same composition. In these cases, the damping peak
for the mixture occurred at an intermediate temperature
between the glass transition temperatures observed for the
homopolymers. If the two polymers in a mixture are insol-
uble, they exist as two separated phases, and two glass
transitions are observed instead of one, as can be seen for
PLLA/PEO blends. Two damping peaks were observed,
which were very close to those in pure PLLA and pure PEO.
These results are in accordance with those obtained from
differential scanning calorimetry, which showed that
PLLA/PEO is an immiscible system. After immersion in a
buffer, samples were far too fragile to allow dynamic-me-
chanical tests.
From the in vivo tests, different bone tissue responses
in the presence of the PLLA, PLLA/PEO blend and PVC
implants were observed. Figures 5 and 6 show the histo-
logical analysis for 2 and 4 week post-implantation periods.
The PLLA implants, as well as the PVC, did not allow the
proliferation of cells. On the other hand, cell proliferation
was observed in animals, which received the PLLA/PEO
blend implants. In the PVC implants, as expected, evidence
of degradation were not visualized. 
For all implants, after 2 and 4 weeks of post-implanta-
tion, a bone tissue growth surrounding the implanted ma-
terial was observed. The neoformed bone presented
non-organized fibers. After 4 weeks of implantation, the
Figure 4. Dynamic-mechanical analysis for (-..-..-) pure PLLA, (-.-.-)
pure PEO, (–) 80/20, (- - -) 50/50 and (. . . .) 20/80 PLLA/PEO blends
(t = 0). (a) Storage modulus and (b) damping as a function of temperature.
Figure 5. Transversal cut of the tibia with implantation of (a) PLLA, (b)
PLLA/PEO blend and (c) PVC after 2 weeks post-surgery. In (a) it is
possible to note the presence of bone growth around the implantation
(arrow). In (b) cell infiltration into the implant (arrow) can be noted. In
(c) it is possible to observe a fibrous tissue (star) in contact with the
implant. Implantation (I), bone tissue (to), muscular tissue (tm) and bone
marrow (mo). 3.2x10 HE.
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formation of a secondary or mature bone could be visua-
lized.
In the PVC group, it was possible to note the presence
of a tissue with a fibrous aspect on the bone defect and also
the presence of inflammatory infiltrated components.
These components were in contact with the implant and in
disperse regions in the collagen fibers for the two experi-
mental periods.
For the PLLA and PLLA/PEO blend implants, the
components of the inflammatory  infiltration demonstrated
low intensity for the first 2 post-surgery weeks, gradually
decreasing after 4 weeks post-implantation. In these cases,
the fibrous tissue, visualized for PVC, was not observed.
The surgical procedures are under way and a histomor-
phometric analysis will allow results with statistical signifi-
cance, to be obtained. However, these preliminary results
show that the PLLA/PEO blends were as biocompatible as
PLLA, with the advantage of the possible control of the
implant degradation rate.
4. Conclusion
PLLA/PEO blends were prepared by the mechanical
mixture and fusion of the homopolymers. Differential scan-
ning calorimetry and dynamic-mechanical analysis
showed that PLLA/PEO blends are an immiscible system.
PLLA/PEO blends after immersion in a buffer had an open
morphology. For blends containing higher PLLA contents,
channels with holes in them, surrounding dense regions
were visualized. By increasing the PEO content, a porous
morphology was verified. This porous morphology can
allow a cell growth distributed throughout the biomedical
devices with the formation of an organized network of the
tissue constituents. 
In vivo tests are under way, but the preliminary results
showed that PLLA/PEO blends were as biocompatible as
the PLLA homopolymer, with the advantage of the possi-
bility of a control of the implant degradation rate. These
materials presented a set of particular properties allowing
their utilization in the manufacture of devices for bone
repair.
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